Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade F 1.35 -1.46% -0.02
NK closed down 1.46 percent on Friday, January 18, 2019, on 26 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NK trend table...

Date Alert Name Type % Chg
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.46%
Jan 17 Narrow Range Bar Range Contraction -1.46%
Jan 17 NR7 Range Contraction -1.46%
Jan 17 Inside Day Range Contraction -1.46%
Jan 17 Wide Bands Range Expansion -1.46%
Jan 16 Wide Bands Range Expansion -1.46%
Jan 16 Overbought Stochastic Strength -1.46%

Older signals for NK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.
Is NK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.47
52 Week Low 0.93
Average Volume 622,938
200-Day Moving Average 2.9332
50-Day Moving Average 1.6542
20-Day Moving Average 1.252
10-Day Moving Average 1.369
Average True Range 0.1454
ADX 15.69
+DI 14.7438
-DI 15.8257
Chandelier Exit (Long, 3 ATRs ) 1.0338
Chandelier Exit (Short, 3 ATRs ) 1.3662
Upper Bollinger Band 1.5308
Lower Bollinger Band 0.9732
Percent B (%b) 0.68
BandWidth 44.536741
MACD Line -0.0551
MACD Signal Line -0.1005
MACD Histogram 0.0454
Fundamentals Value
Market Cap 107.24 Million
Num Shares 79.4 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -1.05
Price-to-Sales 7227.62
Price-to-Book 1.46
PEG Ratio 2.18
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.46
Resistance 3 (R3) 1.46 1.44 1.44
Resistance 2 (R2) 1.44 1.41 1.43 1.43
Resistance 1 (R1) 1.39 1.39 1.38 1.39 1.43
Pivot Point 1.37 1.37 1.36 1.36 1.37
Support 1 (S1) 1.32 1.34 1.31 1.32 1.27
Support 2 (S2) 1.30 1.32 1.29 1.27
Support 3 (S3) 1.25 1.30 1.26
Support 4 (S4) 1.25